Abstract
Clinical and genetic studies in humans and animal models indicate a crucial protective role for the complement system in systemic lupus erythematosus (SLE). This presents a paradox because the complement system is considered to be an important mediator of the inflammation that is observed in patients with SLE. One current view is that complement provides protection by facilitating the rapid removal of apoptotic debris to circumvent an autoimmune response. In this Opinion article, I discuss an alternative model in which complement — together with other components of the innate immune system — participates in the 'presentation' of SLE-inducing self-antigens to developing B cells. In this way, the complement system and innate immunity protect against responses to SLE (self) antigens by enhancing the elimination of self-reactive lymphocytes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Cotran, R. S., Kumar, V. & Robbins, S. L. (eds) in Pathologic Basis of Disease 5th edn 199–208 (W. B. Saunders, Philadelphia, 1994).
Ravetch, J. V. & Bolland, S. IgG Fc receptors. Annu. Rev. Immunol. 19, 275–290 (2001).
Shlomchik, M. J., Madaio, M. P., Ni, D., Trounstein, M. & Huszar, D. The role of B cells in lpr/lpr-induced autoimmunity. J. Exp. Med. 180, 1295–1306 (1994).
Viglianti, G., et al. Activation of autoreactive B cells by CpG dsDNA. Immunity 19, 837–847 (2003).
Casciola-Rosen, L. A., Anhalt, G. & Rosen, A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J. Exp. Med. 179, 1317–1330 (1994).
Reid, K. B. M. & Porter, R. R. The proteolytic activation systems of complement. Annu. Rev. Biochem. 50, 433–464 (1981).
Muller-Eberhard, H. J. Molecular organization and function of the complement system. Annu. Rev. Biochem. 57, 321–347 (1988).
Takahashi, M., Tack, B. F. & Nussenzweig, V. Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes. J. Exp. Med. 145, 86–100 (1977).
Paul, L., Skanes, V. M., Mayden, J. & Levine, R. C4-mediated inhibition of immune precipitation and differences in inhibitory action of genetic variants, C4A3 and C4B1. Complement 5, 110–119 (1988).
Lachmann, P. J. & Walport, M. J. Deficiency of the effector mechanisms of the immune response and autoimmunity. Ciba Found. Symp. 129, 149–171 (1987).
Theofilopoulos, A. N. & Dixon, F. J. Murine models of systemic lupus erythematosus. Adv. Immunol. 37, 269–390 (1985).
Agnello, V. Association of systemic lupus erythematosus and SLE-like syndromes with hereditary and acquired complement deficiency states. Arthritis Rheum. 21, S146–S152 (1978).
Wakeland, E., Wandstrat, A., Liu, K. & Morel, L. Genetic dissection of systemic lupus erythematosus. Curr. Opin. Immunol. 11, 701–707 (1999).
Speirs, C., Fielder, A. H., Chapel, H., Davey, N. J. & Batchelor, J. R. Complement system protein C4 and susceptibility to hydralazine-induced systemic lupus erythematosus. Lancet 1, 922–924 (1989).
Walport, M. J. Complement. Second of two parts. N. Engl. J. Med. 344, 1140–1144 (2001).
Kristjansdottir, H. et al. A study of C4AQ0 and MHC haplotypes in Icelandic multicase families with systemic lupus erythematosus. J. Rheumatol. 27, 2590–2596 (2000).
Steinsson, K. et al. A study of the association of HLA DR, DQ, and complement C4 alleles with systemic lupus erythematosus in Iceland. Ann. Rheum. Dis. 57, 503–505 (1998).
Botto, M. et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nature Genet. 19, 56–59 (1998).
Paul, E., Pozdnyakova, O. O., Mitchell, E. & Carroll, M. C. Anti-DNA autoreactivity in C4-deficient mice. Eur. J. Immunol. 32, 2672–2679 (2002).
Chen, Z., Koralov, S. B. & Kelsoe, G. Complement C4 inhibits systemic autoimmunity through a mechanism independent of complement receptors CR1 and CR2. J. Exp. Med. 192, 1339–1352 (2000).
Botto, M. et al. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nature Med. 3, 855–859 (1997).
Bickerstaff, M. C. et al. Serum amyloid P component controls chromatin degradation and prevents antinuclear autoimmunity. Nature Med. 5, 694–697 (1999).
Napirei, M. et al. Features of systemic lupus erythematosus in DNase1-deficient mice. Nature Genet. 25, 177–181 (2000).
Ehrenstein, M., Cook, H. & Neuberger, M. Deficiency in serum immunoglobulin (Ig) M predisposes to development of IgG autoantibodies. J. Exp. Med. 191, 1253–1258 (2000).
Boes, M. et al. Accelerated development of IgG autoantibodies and autoimmune disease in the absence of secreted IgM. Proc. Natl Acad. Sci. USA 97, 1184–1189 (2000).
Prodeus, A. P. et al. A critical role for complement in maintenance of self-tolerance. Immunity 9, 721–731 (1998).
Wu, X. et al. A role for the Cr2 gene in modifying autoantibody production in systemic lupus erythematosus. J. Immunol. 169, 1587–1592 (2002).
Boackle, S. A. et al. Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity 15, 775–785 (2001).
Hardy, R. R., Carmack, C. E., Li, Y. S. & Hayakawa, K. Distinctive developmental origins and specificities of murine CD5+ B cells. Immunol. Rev. 137, 91–118 (1994).
Herzenberg, L. A. et al. The Ly-1 B cell lineage. Immunol. Rev. 93, 81–102 (1986).
Korb, L. C. & Ahearn, J. M. C1q binds directly and specifically to surface blebs of apoptotic keratinocytes. J. Immunol. 158, 4525–4528 (1997).
Roos, A. et al. A pivotal role for innate immunity in the clearance of apoptotic cells. Eur. J. Immunol. 34, 921–929 (2004).
Nauta, A. J. et al. Mannose-binding lectin engagement with late apoptotic and necrotic cells. Eur. J. Immunol. 33, 2853–2863 (2003).
Ogden, C. A. et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J. Exp. Med. 194, 781–795 (2001).
Taylor, P. R. et al. A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J. Exp. Med. 192, 359–366 (2000).
Ahearn, J. M. & Fearon, D. T. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21). Adv. Immunol. 46, 183–219 (1989).
Kalli, K. R. & Fearon, D. T. Binding of C3b and C4b by the CR1-like site in murine CR1. J. Immunol. 152, 2899–2903 (1994).
Logar, C. M., Chen, W., Schmitt, H., Yu, C. Y. & Birmingham, D. J. A human CR1-like transcript containing sequence for a binding protein for iC4 is expressed in hematopoietic and fetal lymphoid tissue. Mol. Immunol. 40, 831–840 (2004).
Walport, M. J. & Morgan, B. P. Complement deficiency and disease. Immunol. Today 12, 301–306 (1991).
Goodnow, C. C. Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc. Natl Acad. Sci. USA 93, 2264–2271 (1996).
Mevorach, D., Mascarenhas, J. O., Gershov, D. & Elkon, K. B. Complement-dependent clearance of apoptotic cells by human macrophages. J. Exp. Med. 188, 2313–2320 (1998).
Cyster, J. G. & Goodnow, C. C. Antigen-induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity 3, 691–701 (1995).
Fearon, D. & Carroll, M. Regulation of B lymphocyte responses to foreign and self-antigens by the CD19/CD21 complex. Annu. Rev. Immunol. 18, 393–422 (2000).
Cutler, A. et al. T cell-dependent immune response in C1q-deficient mice: defective interferon-γ production by antigen-specific T cells. J. Exp. Med. 187, 1789–1797 (1998).
Boes, M. et al. Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in secreted IgM. J. Immunol. 160, 4776–4787 (1998).
Fischer, M. et al. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol. 157, 549–556 (1996).
DaCosta, X. et al. Humoral response to herpes simplex virus is complement dependent. Proc. Natl Acad. Sci. USA 96, 12708–12712 (1999).
Ahearn, J. et al. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4, 251–262 (1996).
Molina, H. et al. Markedkly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl Acad. Sci. USA 93, 3357–3361 (1996).
Goodnow, C. et al. Self-tolerance checkpoints in B lymphocyte development. Adv. Immunol. 59, 279–368 (1995).
Cutler, A. J. et al. Intact B cell tolerance in the absence of the first component of the classical complement pathway. Eur. J. Immunol. 31, 2087–2093 (2001).
Holmskov, U., Thiel, S. & Jensenius, J. C. Collectins and ficolins: humoral lectins of the innate immune defense. Annu. Rev. Immunol. 21, 547–578 (2003).
Ferry, H., Jones, M., Vaux, D. J., Roberts, I. S. & Cornall, R. J. The cellular location of self-antigen determines the positive and negative selection of autoreactive B cells. J. Exp. Med. 198, 1415–1425 (2003).
Leadbetter, E. A. et al. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416, 603–607 (2002).
Bordet, J. & Gengou, O. Sur l'existence de substances sensibilisatrices dans la plupart des serum antimicrobiens. Ann. Inst. Pasteur (Paris) 15, 289–302 (1901) (in French).
Law, S. K. & Levine, R. P. Interaction between the third complement protein and cell surface macromolecules. Proc. Natl Acad. Sci. USA 74, 2701–2705 (1977).
Law, S. K., Lichtenberg, N. A. & Levine, R. P. Covalent binding and hemolytic activity of complement proteins. Proc. Natl Acad. Sci. USA 77, 7194–7198 (1980).
Isenman, D. E. & Young, J. R. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4. J. Immunol. 132, 3019–3027 (1984).
Tack, B. F., Harrison, R. A., Janatova, J., Thomas, M. L. & Prahl, J. W. Evidence for presence of an internal thiolester bond in third component of human complement. Proc. Natl Acad. Sci. USA 77, 5764–5768 (1980).
Petersen, S. V., Thiel, S. & Jensenius, J. C. The mannan-binding lectin pathway of complement activation: biology and disease association. Mol. Immunol. 38, 133–149 (2001).
Fearon, D. T. & Locksley, R. M. The instructive role of innate immunity in the acquired immune response. Science 272, 50–54 (1996).
Carter, R. H. & Fearon, D. T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256, 105–107 (1992).
Fischer, M. B. et al. Dependence of germinal center B cells on expression of CD21/CD35 for survival. Science 280, 582–585 (1998).
Dempsey, P., Allicson, M., Akkaraju, S., Goodnow, C. & Fearon, D. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271, 348–350 (1996).
Fang, Y., Xu, C., Fu, Y., Holers, V. M. & Molina, H. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG response. J. Immunol. 160, 5273–5279 (1998).
Barrington, R. A., Pozdnyakova, O., Zafari, M. R., Benjamin, C. D. & Carroll, M. C. B lymphocyte memory: role of stromal cell complement and FcγRIIB receptors. J. Exp. Med. 196, 1189–1199 (2002).
Burnet, F. M. The Clonal Selection Theory of Acquired Immunity (Vanderbilt Univ. Press, Nashville, Tennessee, 1959).
King, L. B. & Monroe, J. G. B cell receptor rehabilitation — pausing to reflect. Science 291, 1503–1505 (2001).
Hertz, M. & Nemazee, D. Receptor editing and commitment in B lymphocytes. Curr. Opin. Immunol. 10, 208–213 (1998).
Santulli-Marotto, S., Retter, M. W., Gee, R., Mamula, M. J. & Clarke, S. H. Autoreactive B cell regulation: peripheral induction of developmental arrest by lupus-associated autoantigens. Immunity 8, 209–219 (1998).
Chen, C., Prak, E. L. & Weigert, M. Editing disease-associated autoantibodies. Immunity 6, 97–105 (1997).
Mandik-Nayak, L., Bui, A., Noorchashm, H., Eaton, A. & Erikson, J. Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T–B interface of the splenic follicle. J. Exp. Med. 186, 1257–1267 (1997).
Wardemann, H. et al. Predominant autoantibody production by early human B cell precursors. Science 301, 1374–1377 (2003).
Meffre, E. et al. Surrogate light chain expressing human peripheral B cells produce self-reactive antibodies. J. Exp. Med. 199, 145–150 (2004).
Chen, C. et al. The site and stage of anti-DNA B-cell deletion. Nature 373, 252–255 (1995).
Acknowledgements
I thank past and present members of the laboratory for thoughtful discussions on the topic of innate immunity and B-cell tolerance. Research was supported by the National Institutes of Health, United States.
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Carroll, M. A protective role for innate immunity in systemic lupus erythematosus. Nat Rev Immunol 4, 825–831 (2004). https://doi.org/10.1038/nri1456
Issue Date:
DOI: https://doi.org/10.1038/nri1456
This article is cited by
-
Complement component C1q is an immunological rheostat that regulates Fc:Fc\(\gamma\)R interactions
Immunogenetics (2023)
-
Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus
Nature Immunology (2022)
-
Mesenchymal stem cell therapy induces FLT3L and CD1c+ dendritic cells in systemic lupus erythematosus patients
Nature Communications (2019)
-
Dominant C3 glomerulopathy: new roles for an old actor in renal pathology
Journal of Nephrology (2018)
-
Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology
Clinical and Experimental Nephrology (2018)